RTTNews | Jun 21, 2021 10:29AM EDT

10:29 Monday, June 21, 2021 (RTTNews.com) - Anavex Life Sciences Corp. (AVXL) shares are rising more than 18 percent on Monday morning trade. The company announced positive results from the U.S. Phase 2 study of ANAVEX 2-73 (blarcamesine), the company's drug candidate for the treatment of female adults with Rett syndrome.

The clinical stage biopharmaceutical company said Anavex 2-73 could activate the sigma-1 receptor that could result in restoration of complete housekeeping function with the body and help in restoring neural cell homeostasis and promoting neuroplasticity. Currently, shares are at $26.28, up 18.70 percent from the previous close of $22.14 on a volume of 6,954,157. The shares have traded in a range of $3.65-$28.70 on average volume of 1,580,946.

Read the original article on RTTNews ( https://www.rttnews.com/3203792/stock-alert-anavex-life-sciences-gains-18-on-positive-study-results-for-anavex2-73.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved